Ticker: KPTI
Company: Karyopharm Therapeutics Inc.
Person: Stuart Poulton, officer
Transaction date: July 30, 2024
Reporting date: July 31, 2024
Average share price: 1.06
Sold 2883.0 shares for 3055.98